Initiation of ivabradine in cardiogenic shock

Initiation of ivabradine in cardiogenic shock

Abstract Aims Ivabradine is a selective sinus node inhibitor indicated in patients with symptomatic chronic heart failure on stable guideline‐recommended heart failure therapy including appropriate doses of beta‐blockers. The use in cardiogenic shock remains off label and has been considered a contr...

Full description

Bibliographic Details
Main Authors: Michael H. Chiu, Jonathan G. Howlett, Nakul C. Sharma
Format: Article
Language:English
Published: Wiley 2019-10-01
Series:ESC Heart Failure
Subjects:
Ivabradine
Cardiogenic shock
Heart rate
Heart failure
Vasopressor
Online Access:https://doi.org/10.1002/ehf2.12499

Similar Items

Similar Items